Worldwide Sales in Decline

After regulators overseas approved generic versions of Januvia and Janumet last year, worldwide combined sales of the drugs declined from $3.6 billion to $2.6 billion, or 28%, in the first nine months of 2023.
Figures are in billions of dollars.